USNA
Usana Health Sciences·NYSE
--
--(--)
--
--(--)
USNA fundamentals
Usana Health Sciences (USNA) Revenue Breakdown: Q4 2025 Business & Regional Performance
Usana Health Sciences (USNA) reported total revenue of 226.20M USD in Q4 2025, with its core business segment Asia Pacific contributing 66.80%. Regionally, Asia Pacific remained the largest market, accounting for 65.26% of total revenue. Explore Usana Health Sciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Usana Health Sciences (USNA) reported total revenue of 226.20M USD in Q4 2025, with its core business segment Asia Pacific contributing 66.80%. Regionally, Asia Pacific remained the largest market, accounting for 65.26% of total revenue. Explore Usana Health Sciences's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did Usana Health Sciences beat or miss consensus estimates last quarter?What does Usana Health Sciences do and what are its main business segments?What is the revenue and EPS growth rate for Usana Health Sciences year over year?What is Usana Health Sciences's gross profit margin?What guidance did Usana Health Sciences's management provide for the next earnings period?What factors drove the changes in Usana Health Sciences's revenue and profit?What is Usana Health Sciences's latest dividend and current dividend yield?What were the key takeaways from Usana Health Sciences's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
